Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Phase 2 Clinical Study of TS-142 in Patients with Insomnia Disorder

NCT04573725 is registered in ClinicalTrials.gov with Taisho Pharmaceutical Co., Ltd. as lead sponsor.

NCT NCT04573725
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04573725 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Phase 2 Clinical Study of TS-142 in Patients with Insomnia Disorder
Lead sponsor
Taisho Pharmaceutical Co., Ltd.
Phase
Phase 2
Overall status
Completed
Start date
July 7, 2017
Completion date
February 13, 2019
Enrollment
24 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

insomnia disorder